Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism JNK1 inhibitors(c-Jun N-terminal kinase 1 inhibitors), JNK3 inhibitors(c-Jun N-terminal kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arthritis | Discovery | - | 31 Oct 2024 | |
| Endocrinology and Metabolic Disease | Discovery | - | 31 Oct 2024 | |
| Endometriosis | Discovery | - | 31 Oct 2024 | |
| Neoplasms | Discovery | - | 31 Oct 2024 | |
| Nervous System Diseases | Discovery | - | 31 Oct 2024 | |
| Pulmonary Fibrosis | Discovery | - | 31 Oct 2024 |





